Mark Garzotto

Professor

  • 3632 Citations
  • 30 h-Index
19952019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1995 2019

  • 3632 Citations
  • 30 h-Index
  • 107 Article
  • 1 Chapter
  • 1 Editorial
2019

Dairy Product Consumption and Prostate Cancer Risk in the United States

Preble, I., Zhang, Z., Kopp, R., Garzotto, M., Bobe, G., Shannon, J. J. & Takata, Y., Jul 16 2019, In : Nutrients. 11, 7

Research output: Contribution to journalArticle

Open Access
Dairy Products
prostatic neoplasms
dairy products
Prostatic Neoplasms
dairy consumption
12 Citations (Scopus)

Effect of chemotherapy with docetaxel with androgen suppression and radiotherapy for localized high-risk prostate cancer: The randomized phase III NRG Oncology RTOG 0521 Trial

Rosenthal, S. A., Hu, C., Sartor, O., Gomella, L. G., Amin, M. B., Purdy, J., Michalski, J. M., Garzotto, M., Pervez, N., Balogh, A. G., Rodrigues, G. B., Souhami, L., Reaume, M. N., Williams, S. G., Hannan, R., Horwitz, E. M., Raben, A., Peters, C. A., Feng, F. Y., Shipley, W. U. & 1 others, Sandler, H. M., Jan 1 2019, In : Journal of Clinical Oncology. 37, 14, p. 1159-1168 10 p.

Research output: Contribution to journalArticle

docetaxel
Androgens
Prostatic Neoplasms
Radiotherapy
Drug Therapy
1 Citation (Scopus)

Optimizing the Sequence of Chemotherapy for Upper Tract Urothelial Carcinoma with Clinically Positive Regional Lymph Nodes

Chakiryan, N., Martinez, A., Gao, L., Liu, J-J., Amling, C., Garzotto, M. & Kopp, R., Jul 1 2019, In : The Journal of urology. 202, 1, p. 76-82 7 p.

Research output: Contribution to journalArticle

Lymph Nodes
Carcinoma
Drug Therapy
Survival
Adjuvant Chemotherapy
2 Citations (Scopus)

Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial

Zhang, Z., Garzotto, M., Davis, E. W., Mori, M. T., Stoller, W. A., Farris, P. E., Wong, C. P., Beaver, L. M., Thomas, G., Williams, D. E., Dashwood, R. H., Hendrix, D. A., Ho, E. & Shannon, J. J., Jan 1 2019, In : Nutrition and Cancer.

Research output: Contribution to journalArticle

Brassica
Biological Availability
Prostate
Randomized Controlled Trials
Histone Deacetylases
Prostatectomy
Lymph Node Excision
Lymph Nodes
Logistic Models
Proportional Hazards Models
2018

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421

Lara, P. N., Plets, M., Tangen, C., Gertz, E., Vogelzang, N. J., Hussain, M., Twardowski, P. W., Garzotto, M., Monk, J. P., Carducci, M., Goldkorn, A., Mack, P. C., Thompson, I., Van Loan, M. & Quinn, D. I., Jan 1 2018, In : Cancer Treatment and Research Communications. 16, p. 18-23 6 p.

Research output: Contribution to journalArticle

bis(2,3,3,3-tetrachloropropyl) ether
Bone Remodeling
Castration
Prostatic Neoplasms
Biomarkers
1 Citation (Scopus)

Endorectal MR imaging of prostate cancer: Evaluation of tumor capsular contact length as a sign of extracapsular extension

Mendez, G., Foster, B., Li, X., Shannon, J. J., Garzotto, M., Amling, C. & Coakley, F., Jul 1 2018, In : Clinical Imaging. 50, p. 280-285 6 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Neoplasms
Capsules
Prostate
Prostatectomy
3 Citations (Scopus)
Urinary Bladder Neoplasms
Urinary Bladder
Databases
Drug Therapy
Muscles
2017
1 Citation (Scopus)

Is low-risk prostate cancer more indolent in younger patients?

Garzotto, M., Jun 10 2017, In : Journal of Clinical Oncology. 35, 17, p. 1870-1871 2 p.

Research output: Contribution to journalEditorial

2 Citations (Scopus)

Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421

Sonpavde, G., Pond, G. R., Plets, M., Tangen, C. M., Hussain, M. H. A., Lara, P. N., Goldkorn, A., Garzotto, M., Mack, P. C., Higano, C. S., Vogelzang, N. J., Thompson, I. M., Twardowski, P. W., Van Veldhuizen, P. J., Agarwal, N., Carducci, M. A., Monk, J. P. & Quinn, D. I., Mar 18 2017, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

bis(2,3,3,3-tetrachloropropyl) ether
Castration
Prostatic Neoplasms
docetaxel
Survival
2016
11 Citations (Scopus)

Cyclooxygenase-2 (COX-2) inhibition for prostate cancer chemoprevention: Double-blind randomised study of pre-prostatectomy celecoxib or placebo

Flamiatos, J. F., Beer, T. T., Graff, J., Eilers, K. M., Tian, W., Sekhon, H. S. & Garzotto, M., 2016, (Accepted/In press) In : BJU International.

Research output: Contribution to journalArticle

Celecoxib
Chemoprevention
Cyclooxygenase 2
Prostatectomy
Double-Blind Method
7 Citations (Scopus)

Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlates

Bergstrom, C. P., Ruffell, B., Ho, C. M. T., Higano, C. S., Ellis, W. J., Garzotto, M., Beer, T. T. & Graff, J., Sep 23 2016, (Accepted/In press) In : Anti-Cancer Drugs.

Research output: Contribution to journalArticle

docetaxel
Mitoxantrone
Prostatectomy
Prostatic Neoplasms
Recurrence
2 Citations (Scopus)

Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled Trial

Zhang, Z., Garzotto, M., Beer, T. T., Thuillier, P., Lieberman, S., Mori, M. T., Stoller, W. A., Farris, P. E. & Shannon, J. J., Nov 16 2016, In : Nutrition and Cancer. 68, 8, p. 1309-1319 11 p.

Research output: Contribution to journalArticle

Fatty Acid Synthases
Catechin
Fish Oils
Prostate
Fatty Acids

Gene-expression profiling of localized prostate cancer: Still miles to go before we sleep

Garzotto, M. & Kopp, R., Feb 1 2016, In : Future Oncology. 12, 3, p. 273-276 4 p.

Research output: Contribution to journalArticle

Molecular Diagnostic Techniques
BRCA2 Gene
PTEN Phosphohydrolase
BRCA1 Gene
Nomograms
16 Citations (Scopus)
Contrast Sensitivity
Pharmacokinetics
magnetic resonance
Magnetic Resonance Imaging
scaling
2015
21 Citations (Scopus)

Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial

Goldkorn, A., Ely, B., Tangen, C. M., Tai, Y. C., Xu, T., Li, H., Twardowski, P., Van Veldhuizen, P. J., Agarwal, N., Carducci, M. A., Monk, J. P., Garzotto, M., Mack, P. C., Lara, P., Higano, C. S., Hussain, M., Vogelzang, N. J., Thompson, I. M., Cote, R. J. & Quinn, D. I., Apr 15 2015, In : International Journal of Cancer. 136, 8, p. 1856-1862 7 p.

Research output: Contribution to journalArticle

Circulating Neoplastic Cells
Telomerase
Castration
Prostatic Neoplasms
Survival
2014
11 Citations (Scopus)

Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes

Gordon, R., Wu, M., Huang, C. Y., Harris, W. P., Sim, H. G., Lucas, J. M., Coleman, I., Higano, C. S., Gulati, R., True, L. D., Vessella, R., Lange, P. H., Garzotto, M., Beer, T. T. & Nelson, P. S., Sep 8 2014, In : PLoS One. 9, 9, e104271.

Research output: Contribution to journalArticle

docetaxel
amine oxidase (flavin-containing)
Chemotherapy
Monoamine Oxidase
prostatic neoplasms
166 Citations (Scopus)

Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: A phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer

Goldkorn, A., Ely, B., Quinn, D. I., Tangen, C. M., Fink, L. M., Xu, T., Twardowski, P., Van Veldhuizen, P. J., Agarwal, N., Carducci, M. A., Monk, J. P., Datar, R. H., Garzotto, M., Mack, P. C., Lara, P., Higano, C. S., Hussain, M., Thompson, I. M., Cote, R. J. & Vogelzang, N. J., Apr 10 2014, In : Journal of Clinical Oncology. 32, 11, p. 1136-1142 7 p.

Research output: Contribution to journalArticle

docetaxel
bis(2,3,3,3-tetrachloropropyl) ether
Circulating Neoplastic Cells
Castration
Prostate-Specific Antigen
10 Citations (Scopus)

Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer

Barnett, C. M., Heinrich, M., Lim, J., Nelson, D., Beadling, C., Warrick, A., Neff, T., Higano, C. S., Garzotto, M., Qian, Z. D., Corless, C., Thomas, G. & Beer, T. T., 2014, In : Clinical Cancer Research. 20, 5, p. 1306-1312 7 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Recurrence
Mutation
Survival
Point Mutation
2013
1 Citation (Scopus)

Advances in the Multimodality Management of High-risk Prostate Cancer

Garzotto, M. & Hung, A., Apr 2013, In : Surgical Oncology Clinics of North America. 22, 2, p. 375-394 20 p.

Research output: Contribution to journalArticle

Risk Management
Prostatic Neoplasms
Patient Selection
Neoplasms
Treatment Failure
22 Citations (Scopus)

Agent Orange as a risk factor for high-grade prostate cancer

Ansbaugh, N., Shannon, J. J., Mori, M. T., Farris, P. E. & Garzotto, M., Jul 1 2013, In : Cancer. 119, 13, p. 2399-2404 6 p.

Research output: Contribution to journalArticle

Veterans
Prostatic Neoplasms
Confidence Intervals
Biopsy
Neoplasm Grading
112 Citations (Scopus)

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): A randomised phase 3 trial

Quinn, D. I., Tangen, C. M., Hussain, M., Lara, P. N., Goldkorn, A., Moinpour, C. M., Garzotto, M., Mack, P. C., Carducci, M. A., Monk, J. P., Twardowski, P. W., Van Veldhuizen, P. J., Agarwal, N., Higano, C. S., Vogelzang, N. J. & Thompson, I. M., Aug 2013, In : The Lancet Oncology. 14, 9, p. 893-900 8 p.

Research output: Contribution to journalArticle

docetaxel
bis(2,3,3,3-tetrachloropropyl) ether
Castration
Prostatic Neoplasms
Placebos
23 Citations (Scopus)

Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection

Li, X., Priest, R. A., Woodward, W. J., Tagge, I. J., Siddiqui, F., Huang, W., Rooney, W., Beer, T. T., Garzotto, M. & Springer, C. J., Jan 2013, In : Magnetic Resonance in Medicine. 69, 1, p. 171-178 8 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Pharmacokinetics
Biomarkers
Pathology
Biopsy
2012
20 Citations (Scopus)
Prostatic Hyperplasia
Pathology
Therapeutics
17 Citations (Scopus)

Cell membrane water exchange effects in prostate DCE-MRI

Li, X., Priest, R. A., Woodward, W. J., Siddiqui, F., Beer, T. T., Garzotto, M., Rooney, W. & Springer, C. J., May 2012, In : Journal of Magnetic Resonance. 218, p. 77-85 9 p.

Research output: Contribution to journalArticle

Cell membranes
Magnetic resonance imaging
Prostate
Cell Membrane
Water
2011
4 Citations (Scopus)

Androgen deprivation therapy for prostate cancer: Not so simple

Tadros, N. N. & Garzotto, M., Mar 2011, In : Asian Journal of Andrology. 13, 2, p. 187-188 2 p.

Research output: Contribution to journalArticle

Androgen Antagonists
Hand Strength
Cognition
Androgens
Prostatic Neoplasms
8 Citations (Scopus)

Minimal benefit of an endorectal balloon for prostate immobilization as verified by daily localization

Hung, A., Garzotto, M. & Kaurin, D., 2011, In : Medical Dosimetry. 36, 2, p. 195-199 5 p.

Research output: Contribution to journalArticle

Immobilization
Prostate
Fiducial Markers
Water
Radiotherapy
2010
31 Citations (Scopus)

Acupuncture for hot flashes in patients with prostate cancer

Beer, T. T., Benavides, M., Emmons, S. L., Hayes, M. M., Liu, G., Garzotto, M., Donovan, D., Katovic, N., Reeder, C. & Eilers, K., Nov 2010, In : Urology. 76, 5, p. 1182-1188 7 p.

Research output: Contribution to journalArticle

Hot Flashes
Acupuncture
Prostatic Neoplasms
Quality of Life
Sleep
63 Citations (Scopus)

CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity

Qian, Z. D., Rademacher, B. L. S., Pittsenbarger, J., Huang, C. Y., Myrthue, A., Higano, C. S., Garzotto, M., Nelson, P. S. & Beer, T. T., Mar 1 2010, In : Prostate. 70, 4, p. 433-442 10 p.

Research output: Contribution to journalArticle

docetaxel
Prostatic Neoplasms
Drug Therapy
Phosphatidylinositol 3-Kinases
Phosphorylation
11 Citations (Scopus)

Contemporary management of high-risk localized prostate cancer

Garzotto, M. & Hung, A., May 2010, In : Current Urology Reports. 11, 3, p. 159-164 6 p.

Research output: Contribution to journalArticle

Risk Management
Prostatic Neoplasms
Radiotherapy
Androgens
Therapeutics
1 Citation (Scopus)

Editorial comment

Garzotto, M., 2010, In : Journal of Urology. 184, 2, p. 500 1 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Prostate-Specific Antigen
Prostatic Neoplasms

Editorial Comment

Garzotto, M., Jan 2010, In : Journal of Urology. 183, 1, p. 123-124 2 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms
17 Citations (Scopus)

Erythrocyte fatty acids and prostate cancer risk: A comparison of methods

Shannon, J. J., O'Malley, J., Mori, M. T., Garzotto, M., Palma, A. J. & King, I. B., Sep 2010, In : Prostaglandins Leukotrienes and Essential Fatty Acids. 83, 3, p. 161-169 9 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Fatty Acids
Erythrocytes
Monounsaturated Fatty Acids
Principal Component Analysis
30 Citations (Scopus)

Histologic changes associated with neoadjuvant chemotherapy are predictive of nodal metastases in patients with high-risk prostate cancer

O'Brien, C., True, L. D., Higano, C. S., Rademacher, B. L. S., Garzotto, M. & Beer, T. T., Apr 2010, In : American Journal of Clinical Pathology. 133, 4, p. 654-661 8 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
docetaxel
Neoplasm Metastasis
Recurrence
Drug Therapy
25 Citations (Scopus)

ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21

Geng, H., Rademacher, B. L., Pittsenbarger, J., Huang, C. Y., Harvey, C. T., Lafortune, M. C., Myrthue, A., Garzotto, M., Nelson, P. S., Beer, T. T. & Qian, Z. D., Apr 15 2010, In : Cancer Research. 70, 8, p. 3239-3248 10 p.

Research output: Contribution to journalArticle

docetaxel
Prostatic Neoplasms
DNA
Drug Therapy
Up-Regulation

ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21 (Cancer Research (2010) 70, (3239-3248) DOI: 10.1158/0008-5472. CAN-09-3186)

Geng, H., Rademacher, B. L., Pittsenbarger, J., Huang, C. Y., Harvey, C. T., Lafortune, M. C., Myrthue, A., Garzotto, M., Nelson, P. S., Beer, T. T. & Qian, Z. D., Jun 1 2010, In : Cancer Research. 70, 11, p. 4785 1 p.

Research output: Contribution to journalArticle

docetaxel
Prostatic Neoplasms
Research
Neoplasms
33 Citations (Scopus)

Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer

Garzotto, M., Higano, C. S., O'Brien, C., Rademacher, B. L. S., Janeba, N., Fazli, L., Lange, P. H., Lieberman, S. & Beer, T. T., Apr 1 2010, In : Cancer. 116, 7, p. 1699-1708 10 p.

Research output: Contribution to journalArticle

docetaxel
Mitoxantrone
Prostatic Neoplasms
Recurrence
Prostatectomy
243 Citations (Scopus)

Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer

Zhu, M. L., Horbinski, C. M., Garzotto, M., Qian, Z. D., Beer, T. T. & Kyprianou, N., Oct 15 2010, In : Cancer Research. 70, 20, p. 7992-8002 11 p.

Research output: Contribution to journalArticle

Androgen Receptors
Tubulin
Prostatic Neoplasms
docetaxel
Drug Therapy
2009
30 Citations (Scopus)

Folate intake and prostate cancer risk: A case-control study

Shannon, J. J., Phoutrides, E., Palma, A., Farris, P., Peters, L., Forester, A., Tillotson, C. J. & Garzotto, M., Sep 2009, In : Nutrition and Cancer. 61, 5, p. 617-628 12 p.

Research output: Contribution to journalArticle

Folic Acid
Case-Control Studies
Prostatic Neoplasms
Biopsy
Alcohol Drinking
104 Citations (Scopus)

Lower urinary tract symptoms increase the risk of falls in older men

Parsons, J. K., Mougey, J., Lambert, L., Wilt, T. J., Fink, H. A., Garzotto, M., Barrett-Connor, E. & Marshall, L., Jul 2009, In : BJU International. 104, 1, p. 63-68 6 p.

Research output: Contribution to journalArticle

Lower Urinary Tract Symptoms
Independent Living
Osteoporotic Fractures
Nocturia
Urination
13 Citations (Scopus)

Prostate cancer - Associated gene expression alterations determined from needle biopsies

Qian, Z. D., Huang, C. Y., O'Brien, C. A., Coleman, I. M., Garzotto, M., True, L. D., Higano, C. S., Vessella, R., Lange, P. H., Nelson, P. S. & Beer, T. T., May 1 2009, In : Clinical Cancer Research. 15, 9, p. 3135-3142 8 p.

Research output: Contribution to journalArticle

Neoplasm Genes
Needle Biopsy
Prostate
Prostatic Neoplasms
Gene Expression
2008
29 Citations (Scopus)

A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer

Chan, J. S., Beer, T. T., Quinn, D. I., Pinski, J. K., Garzotto, M., Sokoloff, M., Dehaze, D. R. & Ryan, C., Dec 2008, In : BJU International. 102, 11, p. 1601-1606 6 p.

Research output: Contribution to journalArticle

Mitoxantrone
Calcitriol
Prednisone
Androgens
Prostatic Neoplasms

Reply to neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer

Sonpavde, G., Garzotto, M. & Chi, K. N., Jun 1 2008, In : Cancer. 112, 11, p. 2519 1 p.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Prostatectomy
Prostatic Neoplasms
2 Citations (Scopus)

The natural and treated history of prostate cancer

Garzotto, M., Jan 1 2008, Prostate Cancer. Cambridge University Press, p. 15-28 14 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Prostatic Neoplasms
Neoplasms
Developed Countries
Disease Progression
Life Style
16 Citations (Scopus)

Veterans Affairs Cooperative Studies Program Study 553: Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer

Montgomery, B., Lavori, P., Garzotto, M., Lee, K., Brophy, M., Thaneemit-Chen, S., Kelly, W., Basler, J., Ringer, R., Yu, W., Whittemore, A. & Lin, D. W., Sep 2008, In : Urology. 72, 3, p. 474-480 7 p.

Research output: Contribution to journalArticle

docetaxel
Veterans Hospitals
Taxoids
Veterans
Adjuvant Chemotherapy
2007
11 Citations (Scopus)

Assessment of Prostate-Specific Antigen Doubling Time in Prediction of Prostate Cancer on Needle Biopsy

Spurgeon, S., Mongoue-Tchokote, S., Collins, L., Priest, R., Hsieh, Y. C., Peters, L. M., Beer, T. T., Mori, M. T. & Garzotto, M., May 2007, In : Urology. 69, 5, p. 931-935 5 p.

Research output: Contribution to journalArticle

Needle Biopsy
Prostate-Specific Antigen
Prostatic Neoplasms
Regression Analysis
Digital Rectal Examination
18 Citations (Scopus)

Diethylstilbestrol and docetaxel: A phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer

Montgomery, R. B., Nelson, P. S., Lin, D., Ryan, C., Garzotto, M. & Beer, T. T., Sep 1 2007, In : Cancer. 110, 5, p. 996-1002 7 p.

Research output: Contribution to journalArticle

docetaxel
Diethylstilbestrol
Proxy
Tubulin
Androgens

Editorial Comment

Garzotto, M., Jun 2007, In : Journal of Urology. 177, 6, p. 2135 1 p.

Research output: Contribution to journalArticle

Editorial Comments

Garzotto, M., Dec 2007, In : Journal of Urology. 178, 6, p. 2365 1 p.

Research output: Contribution to journalArticle

51 Citations (Scopus)

Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: Identification of a cytoprotective mechanism involving growth differentiation factor 15

Huang, C. Y., Beer, T. T., Higano, C. S., True, L. D., Vessella, R., Lange, P. H., Garzotto, M. & Nelson, P. S., Oct 1 2007, In : Clinical Cancer Research. 13, 19, p. 5825-5833 9 p.

Research output: Contribution to journalArticle

Growth Differentiation Factor 15
Prostate
docetaxel
Carcinoma
Drug Therapy